REGENXBIO Inc - Bathi saben saham sajrone rolas wulan pungkasan RGNX

This EPS (TTM) chart for REGENXBIO Inc. (RGNX) illustrates earnings dynamics, while the metric stands at 8.20. The business focuses on developing innovative methods to combat blindness and is currently completing the testing phase. REGENXBIO Inc. (RGNX) owns a state-of-the-art manufacturing facility in the United States, ensuring the reliable production of biologics. Licensing royalties for the use of unique patented gene delivery systems provide additional revenue.
regenxbio.com - rincian analitis lan metrik utama (RGNX)

Geopolitical fragmentation and the disruption of biological supply chains are hindering the expansion of gene therapy at REGENXBIO Inc. (RGNX). Under these conditions, the EPS YoY TTM percentage dynamics measure the rate of change in net income per share over a rolling year, neutralizing quarterly gaps. Current fluctuations on this chart reflect the sensitivity of margins to borrowing costs. Investors utilize this indicator to assess capital resilience under negative scenarios.